Kirk SJ, Cooper GG, Hoper M, et al. The prognostic signifycancer of marrow micrometastases in women with early breast cancer[J]. Eur J Surg Oncol, 1990, 16: 481-485.
[5]
Osborne M, Rosen P. Detection and management of bone marrow micrometastases in breast cancer[J]. Oncology, 1994, 8: 25-36.
[6]
Sloane JP, Ormerod MG, Neville AM. Potential pathological application of immunocytochemical methods to the[VAC13] detec tion of micrometastases[J]. Cancer Res, 1980, 40(8): 3079-3082.
[7]
Irene G, Nicolas S, John N, et al. In vivo flow cytometry: A new method for enumerating circulating cancer cells[J]. Cancer Res, 2004, 64: 5044-5047.
[8]
Lee GS, Ryu KS, Rha JG, et al. Multiparametric flow cytometric analysis in a breast cancer cell line (MCF-7)[J]. J Obstet Gynaecol Res, 2002, 28(3): 141-148.
Mikhitarian K, Martin RH, Ruppel MB, et al. Detection of mammaglobin mRNA in peripheral blood is associated with high grade breast cancer: interim results of a prospective cohort study[J]. BMC Cancer, 2008, 8: 55.
[15]
Stathopoulou A, Gizi A, Perraki M, et al. Real- time quantification of CK-19 mRNA-positive cells in peripheral blood of breast cancer patients using the lightcycler system[J]. Clin Cancer Res, 2003, 9(14): 5145.
[16]
Taubert H, Blumke K, Bilkenroth U, et al. Detection of disseminated tumor cells in peripheral blood of patients with breast cancer: correlation to nodal status and occurrence of metastases[J]. Gynecol Oncol, 2004, 92(1): 256.
Cristofanilli M, Budd GT, Ellis MJ, et al. Circulating tumor cells, disease progression, and survival in metastatic breast cancer [J]. N Engl J Med, 2004, 351(8): 781.
[19]
Wong NS, Kahn HJ, Zhang L, et al. Prognostic significance of circulating tumor cells enumerated after filtration enrichment in early and metastatic breast cancer patients [J]. Breast Cancer Res Treat, 2006, 99(1): 63-69.
[20]
Müller S, Stahmann N, Riethdorf S, et al. Circulating tumor cells in breast cancer: correlation to bone marrow micrometastases, heterogeneous response to systemic therapy and low proliferative activity[J]. Clin Cancer Res, 2005, 11(10): 3678-3685.
[21]
Lobodasch K, Frohlich F, Rengsberger M, et al. Quantification of circulating tumour cells for the monitoring of adjuvant therapy in breast cancer: An increase in cell number at completion of therapy is a predictor of early relapse [J]. The Breast, 2007, 16: 211-218.
